Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Precipio Inc (PRPO)

Precipio Inc (PRPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,135
  • Shares Outstanding, K 17,227
  • Annual Sales, $ 3,130 K
  • Annual Income, $ -13,240 K
  • 60-Month Beta 2.90
  • Price/Sales 5.85
  • Price/Cash Flow N/A
  • Price/Book 2.90
Trade PRPO with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.99 +31.66%
on 12/30/20
2.88 -9.03%
on 01/20/21
+0.57 (+27.80%)
since 12/22/20
3-Month
1.91 +37.17%
on 10/30/20
2.88 -9.03%
on 01/20/21
+0.46 (+21.30%)
since 10/22/20
52-Week
0.55 +376.36%
on 04/24/20
8.00 -67.25%
on 07/30/20
+0.50 (+23.58%)
since 01/22/20

Most Recent Stories

More News
Precipio Signs HemeScreen(TM) Deals with Two Leading Oncology Groups

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US, West Cancer Center of Memphis, TN; and New York Cancer & Blood...

PRPO : 2.62 (+6.94%)
Precipio Signs Sales & Marketing Agreement for HemeScreen(TM) with Major Oncology Distributor

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with a major US-based oncology distributor to offer Precipio's HemeScreen POL (Physician Office Lab) program...

PRPO : 2.62 (+6.94%)
Precipio, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 19, 2020 / Precipio, Inc. (NASDAQ:PRPO) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 19, 2020 at 5:00...

PRPO : 2.62 (+6.94%)
Precipio Announces Q3-2020 Shareholder Update Call

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2020 corporate update call on Thursday, November 19 at 5:00 PM ET. The call will include updates on the company's...

PRPO : 2.62 (+6.94%)
Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell(TM)

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase testing for its new IV-cell cytogenetics culturing media.

PRPO : 2.62 (+6.94%)
Precipio Launches its Proprietary HemeScreen(TM) AML (Acute Myeloid Leukemia) Molecular Panel

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen(TM) AML (Acute Myeloid Leukemia) panel both clinically in its CLIA laboratory, and...

PRPO : 2.62 (+6.94%)
Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future Plans

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting a shareholder call to address questions related to the company's COVID-19 strategy. The call will take place on Wednesday,...

PRPO : 2.62 (+6.94%)
Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell(TM)

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS Biotec for the sale and distribution of its proprietary IV-Cell...

PRPO : 2.62 (+6.94%)
Thinking about buying stock in Intrepid Potash, iBio Inc, FAT Brands, Precipio Inc, or Norwegian Cruise Line?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IPI, IBIO, FAT, PRPO, and NCLH.

IBIO : 1.7600 (+20.55%)
IPI : 25.33 (+3.35%)
NCLH : 24.59 (-1.60%)
PRPO : 2.62 (+6.94%)
Precipio Announces Q2-2020 Corporate Update Call For Shareholders

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2020 corporate update call on Monday, August 17 at 5:00 PM ET. The call will include updates on the company's...

PRPO : 2.62 (+6.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class...

See More

Key Turning Points

3rd Resistance Point 3.18
2nd Resistance Point 2.97
1st Resistance Point 2.79
Last Price 2.62
1st Support Level 2.40
2nd Support Level 2.19
3rd Support Level 2.01

See More

52-Week High 8.00
Fibonacci 61.8% 5.15
Fibonacci 50% 4.28
Fibonacci 38.2% 3.40
Last Price 2.62
52-Week Low 0.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar